arformoterol arformoterol arformoterol, sold under the brand name brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (copd). arformoterolclinical datatrade namesbrovanaother namesarformoterol tartrate (usan us)ahfs/drugs.commonographmedlineplusa602023license data us dailymed: arformoterol routes ofadministrationinhalationatc codenonelegal statuslegal status us: ℞-only pharmacokinetic dataprotein binding52–65%elimination half-life26 hoursidentifiers iupac name n-amino]ethyl] phenyl]formamide cas number67346-49-0 ypubchem cid3083544iuphar/bps7479drugbankdb01274 ychemspider2340731 yuniif91h02ebwtkeggd07463d02981chebichebi:408174 ychemblchembl1201137 ncomptox dashboard (epa)dtxsid1023077 dtxsid40110071, dtxsid1023077 chemical and physical dataformulac19h24n2o4molar mass344.411 g·mol−1 inchi inchi=1s/c19h24n2o4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24h,9,11h2,1-2h3,(h,21,22)/t13-,19+/m1/s1 ykey:bpzsycziittybl-yjymszousa-n y ny (what is this?) (verify) it is a long-acting β2 adrenoreceptor agonist (laba) and it is the active (r,r)-(−)-enantiomer of formoterol. it was approved for medical use in the united states in october 2006. it is available as a generic medicine. medical uses arformoterol is indicated for the maintenance treatment of bronchoconstriction in people with chronic obstructive pulmonary disease (copd).